{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:41:58Z","timestamp":1792680118076,"version":"4.5.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"abstract":"<jats:p>Abnormalities in B-lymphocyte CD40 ligand (CD154) expression have been described for a number of immunologic diseases, including B-cell lymphomas. Although functional analysis of the CD154 gene and protein has been extensive, little is known about the mechanisms controlling CD154 expression in activated T cells, and even less is known for normal and malignant B cells. In this study we describe the transcriptional mechanism controlling CD154 expression in large B-cell lymphoma (LBCL). We show that the nuclear factor of activated T cells (NFAT) transcription factor is also constitutively activated in LBCL. We demonstrate that the constitutively active NFATc1 and c-rel members of the NFAT and nuclear factor\u2013\u03baB (NF-\u03baB) families of transcription factors, respectively, directly interact with each other, bind to the CD154 promoter, and synergistically activate CD154 gene transcription. Down-regulation of NFATc1 or c-rel with small interfering RNA (siRNA) or chemical inhibitors inhibits CD154 gene transcription and lymphoma cell growth. These findings suggest that targeting NF-\u03baB and NFAT, by inhibiting the expression of these transcription factors, or interdicting their interaction may provide a therapeutic rationale for patients with non-Hodgkin lymphoma of B-cell origin, and possibly other disorders that display dysregulated CD154 expression.<\/jats:p>","DOI":"10.1182\/blood-2005-03-1167","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T01:54:06Z","timestamp":1123811646000},"page":"3940-3947","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":109,"title":["Constitutive NF-\u03baB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival"],"prefix":"10.1182","volume":"106","author":[{"given":"Lan V.","family":"Pham","sequence":"first","affiliation":[{"name":"From the Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, and the Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archito T.","family":"Tamayo","sequence":"additional","affiliation":[{"name":"From the Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, and the Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda C.","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"From the Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, and the Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Chiu","family":"Lin-Lee","sequence":"additional","affiliation":[{"name":"From the Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, and the Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Ford","sequence":"additional","affiliation":[{"name":"From the Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, and the Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111905040301900_REF1","doi-asserted-by":"crossref","unstructured":"Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle J. Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol. 1996;14: 591-617.","DOI":"10.1146\/annurev.immunol.14.1.591"},{"key":"2019111905040301900_REF2","doi-asserted-by":"crossref","unstructured":"Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A. 1997;94: 1931-1936.","DOI":"10.1073\/pnas.94.5.1931"},{"key":"2019111905040301900_REF3","doi-asserted-by":"crossref","unstructured":"Pinchuk LM, Klaus SJ, Magaletti DM, Pinchuk GV, Norsen JP, Clark EA. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol. 1996;157: 4363-4370.","DOI":"10.4049\/jimmunol.157.10.4363"},{"key":"2019111905040301900_REF4","doi-asserted-by":"crossref","unstructured":"Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol. 1995;154: 4996-5010.","DOI":"10.4049\/jimmunol.154.10.4996"},{"key":"2019111905040301900_","doi-asserted-by":"crossref","unstructured":"Crow MK, Kirou KA. Regulation of CD40 ligand expression in systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13: 361-369.","DOI":"10.1097\/00002281-200109000-00004"},{"key":"2019111905040301900_","doi-asserted-by":"crossref","unstructured":"Higuchi T, Aiba Y, Nomura T, et al. Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol. 2002;168: 9-12.","DOI":"10.4049\/jimmunol.168.1.9"},{"key":"2019111905040301900_REF7","doi-asserted-by":"crossref","unstructured":"Cron RQ. CD154 Transcriptional regulation in primary human CD4 T cells. Immunol Res. 2003;27: 185-202.","DOI":"10.1385\/IR:27:2-3:185"},{"key":"2019111905040301900_REF8","doi-asserted-by":"crossref","unstructured":"Clodi K, Asgary Z, Zhao S, et al. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells. Br J Haematol. 1998;103: 270-275.","DOI":"10.1046\/j.1365-2141.1998.01031.x"},{"key":"2019111905040301900_REF9","doi-asserted-by":"crossref","unstructured":"Bishop GA, Hostager BS. Signaling by CD40 and its mimics in B cell activation. Immunol Res. 2001;24: 97-109.","DOI":"10.1385\/IR:24:2:097"},{"key":"2019111905040301900_REF10","doi-asserted-by":"crossref","unstructured":"Pham LV, Tamayo AT, Yoshimura LC, et al. A CD40 signalosome anchored in lipid rafts leads to constitutive activation of NF-\u03baB and autonomous cell growth in B cell lymphomas. Immunity. 2002;16: 37-50.","DOI":"10.1016\/S1074-7613(01)00258-8"},{"key":"2019111905040301900_REF11","doi-asserted-by":"crossref","unstructured":"Schubert LA, King G, Cron RQ, Lewis DB, Aruffo A, Hollenbaugh D. The human gp39 promoter: two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation. J Biol Chem. 1995;270: 29624-29627.","DOI":"10.1074\/jbc.270.50.29624"},{"key":"2019111905040301900_REF12","doi-asserted-by":"crossref","unstructured":"Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15: 707-747.","DOI":"10.1146\/annurev.immunol.15.1.707"},{"key":"2019111905040301900_REF13","doi-asserted-by":"crossref","unstructured":"Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell. 2002;109: S67-S79.","DOI":"10.1016\/S0092-8674(02)00699-2"},{"key":"2019111905040301900_","doi-asserted-by":"crossref","unstructured":"Hogan PG, Chen L, Nardone, J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003;17: 2205-2232.","DOI":"10.1101\/gad.1102703"},{"key":"2019111905040301900_REF15","doi-asserted-by":"crossref","unstructured":"Porter CM, Clipstone NA. Sustained NFAT signaling promotes a Th1-like pattern of gene expression in primary muring CD4+ T cells. J Immunol. 2002;168: 4936-4945.","DOI":"10.4049\/jimmunol.168.10.4936"},{"key":"2019111905040301900_REF16","doi-asserted-by":"crossref","unstructured":"Ford RJ, Goodacre A, Ramirez I, Mehta, SR, and Cabanillas F. Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor. Blood. 1990;75: 1311-1318.","DOI":"10.1182\/blood.V75.6.1311.1311"},{"key":"2019111905040301900_REF17","doi-asserted-by":"crossref","unstructured":"Pham LV, Tamayo AT, Yoshimura LC, Lo P, Ford RJ. Inhibition of constitutive NF-\u03baB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. J Immunol. 2003;171: 88-95.","DOI":"10.4049\/jimmunol.171.1.88"},{"key":"2019111905040301900_REF18","doi-asserted-by":"crossref","unstructured":"Lobo FM, Xu S, Lee C, Fuleihan RL. Transcriptional activity of the distal CD40 ligand promoter. Biochem Biophys Res Commun. 2000;279: 245-250.","DOI":"10.1006\/bbrc.2000.3914"},{"key":"2019111905040301900_REF19","doi-asserted-by":"crossref","unstructured":"Srahna M, Remacle JE, Annamalai K, et al. NF-kB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells. Clin Exp Immunol. 2001;125; 229-236.","DOI":"10.1046\/j.1365-2249.2001.01601.x"},{"key":"2019111905040301900_REF20","doi-asserted-by":"crossref","unstructured":"Yang TT, Chow CW. Transcription cooperation by NFAT:C\/EBP composite enhancer complex. J Biol Chem. 2003;278: 15874-15885.","DOI":"10.1074\/jbc.M211560200"},{"key":"2019111905040301900_REF21","doi-asserted-by":"crossref","unstructured":"Northrop JP, Ho SN, Chen L, et al. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature. 1994;369: 497-502.","DOI":"10.1038\/369497a0"},{"key":"2019111905040301900_REF22","doi-asserted-by":"crossref","unstructured":"Edelstein LC, Lagos L, Simmons M, Tirumalai H, Gelinas C. NF-\u03baB-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1\/A1. Mol Cell Biol. 2003;23: 2749-2761.","DOI":"10.1128\/MCB.23.8.2749-2761.2003"},{"key":"2019111905040301900_REF23","doi-asserted-by":"crossref","unstructured":"Gilmore TD. The Re1\/NF-\u03baB\/I\u03baB signal transduction pathway and cancer. Cancer Treat Res. 2003;115: 241-265.","DOI":"10.1007\/0-306-48158-8_10"},{"key":"2019111905040301900_REF24","doi-asserted-by":"crossref","unstructured":"Yaseen RN, Maizel LA, Wang F, Sharma S. Comparative analysis of NFAT (nuclear factor of activated T cells) complex in human T and B lymphocytes. J Biol Chem. 1993;268: 14285-14293.","DOI":"10.1016\/S0021-9258(19)85239-0"},{"key":"2019111905040301900_REF25","doi-asserted-by":"crossref","unstructured":"Marafioti T, Pozzobon M, Hansmann ML, et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol. 2005;128: 333-342.","DOI":"10.1111\/j.1365-2141.2004.05313.x"},{"key":"2019111905040301900_REF26","doi-asserted-by":"crossref","unstructured":"van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 2000;67: 2-17.","DOI":"10.1002\/jlb.67.1.2"},{"key":"2019111905040301900_REF27","doi-asserted-by":"crossref","unstructured":"Sica A, Dorman L, Viggiano V, et al. Interaction of NF-\u03baB and NFAT with the interferon-gamma promoter. J Biol Chem. 1997;272: 30412-30420.","DOI":"10.1074\/jbc.272.48.30412"},{"key":"2019111905040301900_REF28","doi-asserted-by":"crossref","unstructured":"Li-Weber M, Giaisi M, Baumann S, Palfi K, Krammer PH. NF-\u03baB synergizes with NFAT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol. 2004;34: 1111-1118.","DOI":"10.1002\/eji.200324687"},{"key":"2019111905040301900_REF29","doi-asserted-by":"crossref","unstructured":"Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-\u03b2 promoter. Cell. 2000;103: 667-678.","DOI":"10.1016\/S0092-8674(00)00169-0"},{"key":"2019111905040301900_REF30","doi-asserted-by":"crossref","unstructured":"Merika M, Thanos D. Enhanceosomes. Curr Opin Genet Dev. 2001;11: 205-208.","DOI":"10.1016\/S0959-437X(00)00180-5"},{"key":"2019111905040301900_REF31","doi-asserted-by":"crossref","unstructured":"Chen L, Glover JN, Hogan PG, Rao A, Harrison SC. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature. 1998;392: 42-48.","DOI":"10.1038\/32100"},{"key":"2019111905040301900_REF32","doi-asserted-by":"crossref","unstructured":"Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A. TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokines genes. Nat Immunol. 2002;2: 643-651.","DOI":"10.1038\/ni808"},{"key":"2019111905040301900_REF33","doi-asserted-by":"crossref","unstructured":"de Lumley M, Hart DJ, Cooper MA, Symeonides S, Blackburn JM. A biophysical characterization of factors controlling dimerisation and selectivity in the NF-\u03baB and NFAT families. J Mol Biol. 2004;339: 1059-1075.","DOI":"10.1016\/j.jmb.2004.03.083"},{"key":"2019111905040301900_REF34","doi-asserted-by":"crossref","unstructured":"Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene. 2004;23: 2275-2286.","DOI":"10.1038\/sj.onc.1207410"},{"key":"2019111905040301900_REF35","doi-asserted-by":"crossref","unstructured":"Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene. 2001;20: 7098-7103.","DOI":"10.1038\/sj.onc.1204898"},{"key":"2019111905040301900_REF36","doi-asserted-by":"crossref","unstructured":"Neal JW, Clipstone NA. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J Biol Chem. 2003;278: 17246-17254.","DOI":"10.1074\/jbc.M300528200"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/12\/3940\/458505\/zh802305003940.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/12\/3940\/458505\/zh802305003940.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T04:12:43Z","timestamp":1683173563000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/12\/3940\/109763\/Constitutive-NF%CE%BAB-and-NFAT-activation-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-03-1167","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}